Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Common Stock, balance at beginning of period (in shares) at Dec. 31, 2022		8,267,968
Treasury Stock, balance at beginning of period (in shares) at Dec. 31, 2022			15,740
Balance at beginning of period at Dec. 31, 2022	$ 59,584	$ 82	$ (170)	$ 187,164	$ (127,483)	$ (9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	586			586
Stock issued upon vesting of restricted stock units (in shares)		4,029
Shares surrendered for tax withholding on vested awards (in shares)		(1,007)	(1,007)
Shares surrendered for tax withholding on vested awards	(4)		$ (4)
Repurchases of common stock (in shares)		(87,694)
Repurchases of common stock	(305)	$ (1)		(304)
Other comprehensive income (loss)	4					4
Net loss	(7,346)				(7,346)
Common Stock, balance at end of period (in shares) at Mar. 31, 2023		8,183,296
Treasury Stock, balance at end of period (in shares) at Mar. 31, 2023			16,747
Balance at end of period at Mar. 31, 2023	52,519	$ 81	$ (174)	187,446	(134,829)	(5)
Common Stock, balance at beginning of period (in shares) at Dec. 31, 2022		8,267,968
Treasury Stock, balance at beginning of period (in shares) at Dec. 31, 2022			15,740
Balance at beginning of period at Dec. 31, 2022	59,584	$ 82	$ (170)	187,164	(127,483)	(9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(24,577)
Common Stock, balance at end of period (in shares) at Sep. 30, 2023		7,914,582
Treasury Stock, balance at end of period (in shares) at Sep. 30, 2023			23,173
Balance at end of period at Sep. 30, 2023	35,492	$ 79	$ (196)	187,673	(152,060)	(4)
Common Stock, balance at beginning of period (in shares) at Mar. 31, 2023		8,183,296
Treasury Stock, balance at beginning of period (in shares) at Mar. 31, 2023			16,747
Balance at beginning of period at Mar. 31, 2023	52,519	$ 81	$ (174)	187,446	(134,829)	(5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	653			653
Stock issued/sale under stock purchase plan (in shares)		6,425
Stock issued/sale under stock purchase plan	18			18
Stock issued upon vesting of restricted stock units (in shares)		15,372
Shares surrendered for tax withholding on vested awards (in shares)		(3,828)	(3,828)
Shares surrendered for tax withholding on vested awards	(13)		$ (13)
Repurchases of common stock (in shares)		(159,920)
Repurchases of common stock	(579)	$ (1)		(578)
Other comprehensive income (loss)	(6)					(6)
Net loss	(8,931)				(8,931)
Common Stock, balance at end of period (in shares) at Jun. 30, 2023		8,041,345
Treasury Stock, balance at end of period (in shares) at Jun. 30, 2023			20,575
Balance at end of period at Jun. 30, 2023	43,661	$ 80	$ (187)	187,539	(143,760)	(11)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	559			559
Stock issued upon vesting of restricted stock units (in shares)		8,163
Shares surrendered for tax withholding on vested awards (in shares)		(2,598)	(2,598)
Shares surrendered for tax withholding on vested awards	(9)		$ (9)
Repurchases of common stock (in shares)		(132,328)
Repurchases of common stock	(426)	$ (1)		(425)
Other comprehensive income (loss)	7					7
Net loss	(8,300)				(8,300)
Common Stock, balance at end of period (in shares) at Sep. 30, 2023		7,914,582
Treasury Stock, balance at end of period (in shares) at Sep. 30, 2023			23,173
Balance at end of period at Sep. 30, 2023	$ 35,492	$ 79	$ (196)	187,673	(152,060)	$ (4)
Common Stock, balance at beginning of period (in shares) at Dec. 31, 2023	8,102,555	8,102,555
Treasury Stock, balance at beginning of period (in shares) at Dec. 31, 2023	23,173		23,173
Balance at beginning of period at Dec. 31, 2023	$ 27,305	$ 81	$ (196)	188,937	(161,517)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	580			580
Stock issued upon vesting of restricted stock units (in shares)		6,279
Shares surrendered for tax withholding on vested awards (in shares)		(1,713)	(1,713)
Shares surrendered for tax withholding on vested awards	(5)		$ (5)
Net loss	(10,441)				(10,441)
Common Stock, balance at end of period (in shares) at Mar. 31, 2024		8,107,121
Treasury Stock, balance at end of period (in shares) at Mar. 31, 2024			24,886
Balance at end of period at Mar. 31, 2024	$ 17,439	$ 81	$ (201)	189,517	(171,958)
Common Stock, balance at beginning of period (in shares) at Dec. 31, 2023	8,102,555	8,102,555
Treasury Stock, balance at beginning of period (in shares) at Dec. 31, 2023	23,173		23,173
Balance at beginning of period at Dec. 31, 2023	$ 27,305	$ 81	$ (196)	188,937	(161,517)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (25,459)
Common Stock, balance at end of period (in shares) at Sep. 30, 2024	8,648,243	8,648,243
Treasury Stock, balance at end of period (in shares) at Sep. 30, 2024	30,810		30,810
Balance at end of period at Sep. 30, 2024	$ 4,914	$ 86	$ (215)	192,019	(186,976)
Common Stock, balance at beginning of period (in shares) at Mar. 31, 2024		8,107,121
Treasury Stock, balance at beginning of period (in shares) at Mar. 31, 2024			24,886
Balance at beginning of period at Mar. 31, 2024	17,439	$ 81	$ (201)	189,517	(171,958)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	387			387
Stock issued/sale under stock purchase plan (in shares)		5,705
Stock issued/sale under stock purchase plan	11			11
Stock issued upon vesting of restricted stock units (in shares)		14,188
Shares surrendered for tax withholding on vested awards (in shares)		(3,828)	(3,828)
Shares surrendered for tax withholding on vested awards	(11)		$ (11)
Net loss	(7,551)				(7,551)
Common Stock, balance at end of period (in shares) at Jun. 30, 2024		8,123,186
Treasury Stock, balance at end of period (in shares) at Jun. 30, 2024			28,714
Balance at end of period at Jun. 30, 2024	10,275	$ 81	$ (212)	189,915	(179,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	379			379
Stock issued under the Controlled Equity OfferingSM, net of costs (in shares)		520,091
Stock issued under the Controlled Equity OfferingSM, net of costs	1,730	$ 5		1,725
Stock issued upon vesting of restricted stock units (in shares)		7,062
Shares surrendered for tax withholding on vested awards (in shares)		(2,096)	(2,096)
Shares surrendered for tax withholding on vested awards	(3)		$ (3)
Net loss	$ (7,467)				(7,467)
Common Stock, balance at end of period (in shares) at Sep. 30, 2024	8,648,243	8,648,243
Treasury Stock, balance at end of period (in shares) at Sep. 30, 2024	30,810		30,810
Balance at end of period at Sep. 30, 2024	$ 4,914	$ 86	$ (215)	$ 192,019	$ (186,976)